West Family Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,091
Closed -$277K 330
2021
Q4
$277K Sell
1,091
-107
-9% -$31.3K 0.08% 222
2021
Q3
$461K Buy
1,198
+68
+6% +$25.1K 0.12% 147
2021
Q2
$266K Buy
+1,130
New +$202K 0.07% 256

Other funds holding MRNA

West Family Investments's MRNA Position: Q1 2022 in Review

West Family Investments sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,091 shares — an estimated $277K sold.

West Family Investments first reported a position in MRNA in Q2 2021 and held it in 3 quarters. The position peaked at $461K in Q3 2021. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • West Family Investments reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • West Family Investments sold 1,091 Moderna shares in Q1 2022, an estimated $277K.
  • West Family Investments first reported a position in Moderna in Q2 2021 and held it in 3 quarters.
  • West Family Investments's Moderna position peaked at $461K in Q3 2021.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on West Family Investments's 13F filing for Q1 2022, filed 13 May 2022.